(NYSE: CBT) Cabot's forecast annual revenue growth rate of 2.03% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.77%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.44%.
Cabot's revenue in 2026 is $3,607,000,000.On average, 6 Wall Street analysts forecast CBT's revenue for 2026 to be $187,945,552,796, with the lowest CBT revenue forecast at $176,979,015,956, and the highest CBT revenue forecast at $201,418,726,628. On average, 6 Wall Street analysts forecast CBT's revenue for 2027 to be $193,376,599,612, with the lowest CBT revenue forecast at $182,566,727,584, and the highest CBT revenue forecast at $206,327,557,404.
In 2028, CBT is forecast to generate $200,322,072,944 in revenue, with the lowest revenue forecast at $189,146,649,688 and the highest revenue forecast at $215,048,565,272.